2-Chloro-5-methylpyridine, 97.0%, 1g

1-N-BOC-4-N-BENZYL-2-BENZYL PIPERAZINE, 95.0%, 1g

Sodium 2-oxohexanoate, 98%, 1g

N-(4-methoxybenzyl)butan-1-amine, 95.0%, 10g

Microliter syringe GASTIGHT® series 1700 Point type 2, 50 µl, 1705 RN, 1 piece

4-Hydroxy-2-(4-trifluoromethyl-phenyl)-thiazole-5-carboxylic acidethylester, 250mg

2-Chloroisonicotinaldehyde, 97.0%, 1g

Isoxazolo[4,5-b]pyridin-3-amine, 95.0%, 1g

1-Amino-3-(2-methoxyphenoxy)propan-2-ol, 95+%, 1g

1-Amino-4-bromoanthraquinone-2-sulfonic Acid Sodium Salt>98.0%(HPLC)500g

3-Methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3H-imidazo[4,5-b]pyridine, 95.0%, 1g

BUTANE-1-SULFONYL FLUORIDE, 95%, 5g

Isopropylboronic Acid (contains varying amounts of Anhydride)5g